These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 25967649

  • 1. Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer.
    Mizushima T, Tamagawa H, Matsuda C, Murata K, Fukunaga M, Ota H, Hasegawa J, Tsujie M, Fukuzaki T, Hata T, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M.
    Oncology; 2015; 89(3):152-8. PubMed ID: 25967649
    [Abstract] [Full Text] [Related]

  • 2. Uracil-Tegafur and Oral Leucovorin Combined With Bevacizumab in Elderly Patients (Aged ≥ 75 Years) With Metastatic Colorectal Cancer: A Multicenter, Phase II Trial (Joint Study of Bevacizumab, Oral Leucovorin, and Uracil-Tegafur in Elderly Patients [J-BLUE] Study).
    Nishina T, Moriwaki T, Shimada M, Higashijima J, Sakai Y, Masuishi T, Ozeki M, Amagai K, Negoro Y, Indo S, Denda T, Sato M, Yamamoto Y, Nakajima G, Mizuta M, Takahashi I, Hiroshima Y, Ishida H, Maeba T, Hyodo I.
    Clin Colorectal Cancer; 2016 Sep; 15(3):236-42. PubMed ID: 26778644
    [Abstract] [Full Text] [Related]

  • 3. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
    Yamada Y, Takahari D, Matsumoto H, Baba H, Nakamura M, Yoshida K, Yoshida M, Iwamoto S, Shimada K, Komatsu Y, Sasaki Y, Satoh T, Takahashi K, Mishima H, Muro K, Watanabe M, Sakata Y, Morita S, Shimada Y, Sugihara K.
    Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
    Shirao K, Hoff PM, Ohtsu A, Loehrer PJ, Hyodo I, Wadler S, Wadleigh RG, O'Dwyer PJ, Muro K, Yamada Y, Boku N, Nagashima F, Abbruzzese JL.
    J Clin Oncol; 2004 Sep 01; 22(17):3466-74. PubMed ID: 15277535
    [Abstract] [Full Text] [Related]

  • 5. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
    Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, Vincent MD, Lembersky BC, Thompson S, Maniero A, Benner SE.
    J Clin Oncol; 2002 Sep 01; 20(17):3605-16. PubMed ID: 12202661
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
    Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S, Martin C.
    J Clin Oncol; 2002 Sep 01; 20(17):3617-27. PubMed ID: 12202662
    [Abstract] [Full Text] [Related]

  • 7. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
    Bin Q, Li J, Liao C, Cao Y, Gao F.
    Colorectal Dis; 2011 Aug 01; 13(8):837-45. PubMed ID: 20050863
    [Abstract] [Full Text] [Related]

  • 8. Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.
    Hsiao SC, Lin JF, Chuang MT, Lee YA, Wu DL.
    Int Surg; 2009 Aug 01; 94(4):298-303. PubMed ID: 20302025
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of oxaliplatin and tegafur/uracil and oral folinic acid for advanced or metastatic colorectal cancer in elderly patients.
    Rosati G, Cordio S, Tucci A, Blanco G, Bordonaro R, Reggiardo G, Manzione L.
    Oncology; 2005 Aug 01; 69(2):122-9. PubMed ID: 16118508
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.
    Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV, Markowitz AB, Abbruzzese JL, Bready B.
    J Clin Oncol; 1994 Nov 01; 12(11):2296-300. PubMed ID: 7964943
    [Abstract] [Full Text] [Related]

  • 11. Survival benefit of oral tegafur/uracil and leucovorin as a first line therapy for elderly patients with advanced or metastatic colorectal cancer.
    Murata K, Yamamoto H, Fukunaga M, Kato T, Ohnishi T, Uemura Y, Ohta H, Kimura F, Ohue M, Nezu R, Sekimoto M, Ikeda M, Mizushimaz T, Doki Y, Mori M, Clinical Study Group of Osaka University (CSGO) Colorectal Group.
    Hepatogastroenterology; 2014 Nov 01; 61(129):94-8. PubMed ID: 24895801
    [Abstract] [Full Text] [Related]

  • 12. A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer.
    Mackay HJ, Hill M, Twelves C, Glasspool R, Price T, Campbell S, Massey A, Macham MA, Uzzel M, Bailey SM, Martin C, Cunningham D.
    Ann Oncol; 2003 Aug 01; 14(8):1264-9. PubMed ID: 12881390
    [Abstract] [Full Text] [Related]

  • 13. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299.
    Hochster HS, Luo W, Popa EC, Lyman BT, Mulcahy M, Beatty PA, Benson AB.
    J Clin Oncol; 2007 Dec 01; 25(34):5397-402. PubMed ID: 18048821
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
    Mizushima T, Mizuno H, Ito T, Hoki M, Souma Y, Iwamoto T, Ozawa H, Kanou T, Nakamori Y, Iwase K.
    Gan To Kagaku Ryoho; 2006 Jul 01; 33(7):941-4. PubMed ID: 16835484
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients.
    Okabayashi K, Hasegawa H, Ishii Y, Endo T, Ochiai H, Kubota T, Kitagawa Y.
    Cancer Chemother Pharmacol; 2009 Feb 01; 63(3):501-7. PubMed ID: 18461329
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT, Yoon SY, Shin SW, Kim BS, Mok YJ, Kim CS, Hyun JH, Kim JS, Kim YH.
    Cancer; 2001 Jun 15; 91(12):2288-93. PubMed ID: 11413517
    [Abstract] [Full Text] [Related]

  • 17. Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study.
    Sheikh HY, Valle JW, Palmer K, Sjursen A, Craven O, Wilson G, Swindell R, Saunders MP.
    Br J Cancer; 2007 Jan 15; 96(1):38-43. PubMed ID: 17213824
    [Abstract] [Full Text] [Related]

  • 18. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
    Shibahara K, Yamamoto M, Kakeji Y, Sakata H, Maehara Y.
    Anticancer Res; 2008 Jan 15; 28(3B):1779-83. PubMed ID: 18630459
    [Abstract] [Full Text] [Related]

  • 19. Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.
    Méndez M, Alfonso PG, Pujol E, González E, Castañon C, Cerezuela P, López-Mateos Y, Cruz JJ.
    Invest New Drugs; 2005 Jun 15; 23(3):243-51. PubMed ID: 15868381
    [Abstract] [Full Text] [Related]

  • 20. Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: final results of JCOG0205.
    Shimada Y, Hamaguchi T, Mizusawa J, Saito N, Kanemitsu Y, Takiguchi N, Ohue M, Kato T, Takii Y, Sato T, Tomita N, Yamaguchi S, Akaike M, Mishima H, Kubo Y, Nakamura K, Fukuda H, Moriya Y.
    Eur J Cancer; 2014 Sep 15; 50(13):2231-40. PubMed ID: 24958736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.